MWM
AUPH icon

MinichMacGregor Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

MinichMacGregor Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-360
Closed -$1K – 527
2018
Q1 		$1K Buy
+360
New +$1.93K ﹤0.01% 446

Other funds holding AUPH

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CWM
Cornerstone Wealth Management St. Peters, Missouri $2.33B AUM 25.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

MinichMacGregor Wealth Management's AUPH Position: Q2 2018 in Review

MinichMacGregor Wealth Management sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2018, closing a stake of 360 shares — an estimated $1K sold.

MinichMacGregor Wealth Management first reported a position in AUPH in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 67 funds tracked by Wall St. Rank hold AUPH as of Q2 2018.

  • MinichMacGregor Wealth Management reported no remaining Aurinia Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • MinichMacGregor Wealth Management sold 360 Aurinia Pharmaceuticals shares in Q2 2018, an estimated $1K.
  • MinichMacGregor Wealth Management first reported a position in Aurinia Pharmaceuticals in Q1 2018 and held it in 1 quarter.
  • MinichMacGregor Wealth Management's Aurinia Pharmaceuticals position peaked at $1K in Q1 2018.
  • 67 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2018.

Based on MinichMacGregor Wealth Management's 13F filing for Q2 2018, filed 13 Jul 2018.